Around four years ago, Almirall decided to become a Derma company.
Since then, almost all derma experts in development (present in the German, Swiss and US centres) left the company.
Now, the Spanish R&D site without relevant derma expertise is in charge - governed by some ex-Allergan managers from the US with whom they 'collaborate' based on an intense mutual dislike.
Some numbers: in the four years before Almirall became a 'Derma company', it conducted around 8 clinical trials on own development projects through its expert affiliates in the US/Germany/Switzerland. In the four years after the switch to derma, the number was zero (yes, zero) for own projects.
most people are nice as person...
defending the status quo prevails the ambition to build up necessary capabilities